CAMBRIDGE, Mass.–(BUSINESS WIRE)– VBI Vaccines (Nasdaq: VBIV) (VBI), a biopharmaceutical firm pushed by immunology in the pursuit of highly effective prevention and therapy of illness, at this time introduced that PreHevbrio™ [Hepatitis B Vaccine (Recombinant)] is now obtainable in the United States for the prevention of an infection attributable to all identified subtypes of hepatitis […]

The post VBI Vaccines Announces PreHevbrio™ is Now Available in the United States for the Prevention of Hepatitis B in Adults & More Insurance News appeared first on CableFreeTV.

Leave a Reply

Your email address will not be published.